ISPOR Impact Award

Amy Nunn is a public health leader, professor, and CEO of the Rhode Island Public Health Institute. She is widely recognized for developing innovative, practical solutions to major public health challenges in the United States.

She holds advanced degrees in global health from the Harvard T.H. Chan School of Public Health and completed postdoctoral training at Brown University, where she is also a professor. Throughout her career, she has trained hundreds of students and professionals to design creative approaches to complex health problems.

Dr. Nunn has led impactful public health advocacy efforts, including expanding access to HIV prevention through programs like PrEP for All and improving nutrition access through Eat Well Be Well. Her work has influenced policy and improved health outcomes at both local and national levels.

She is also an author of the book The Politics and History of AIDS Treatment in Brazil, and her work has been featured in major media outlets such as The New York Times and BBC.

Beyond research and policy, Dr. Nunn is committed to social justice and interdisciplinary collaboration. A former Fulbright Program scholar, she brings a global perspective to her work and is passionate about languages, travel, and building strong teams to address complex public health issues.

Jalpa A. Doshi is a leading health economist and professor at the University of Pennsylvania, where she also directs value-based insurance design initiatives. Over more than 20 years, she has built a major research program focused on improving access to medications, ensuring they are affordable, and maximizing their value for patients.

Her work uses health economics and policy research to study how drugs are accessed, used, and priced across different diseases and populations. It has had a direct influence on real-world policies, including programs like Medicare Part D and the Veterans Health Administration, helping improve medication adherence and patient outcomes.

Dr. Doshi has also contributed to advancing research methods in pharmaceutical economics, making evidence more useful for healthcare decision-makers. Her work has earned recognition from major organizations such as ISPOR and has been featured in prominent media outlets.

Beyond research, she is a dedicated mentor and educator, teaching globally and supporting the development of future researchers. She has held leadership roles in professional societies, contributed to major academic journals, and co-authored the book Economic Evaluation in Clinical Trials, a key reference in the field.

Dr. Dean is Associate Professor in Epidemiology at Johns Hopkins Bloomberg School of Public Health. As a social epidemiologist, her work focuses on privilege and health, including social (racism, discrimination, social capital) and economic (consumer credit, socioeconomic position) determinants of disparities in cancer and HIV. She is co-author of the newly released book Power, Privilege and Public Health: Theory and Practice. She has led several studies as PI of NIH, Robert Wood Johnson Foundation, Center for AIDS Research, and institutional grants. She holds a doctorate from Harvard School of Public Health and was a J. William Fulbright program awardee to Venezuela.

Rachael L. Fleurence, PhD, MSc, is the former Senior Advisor to Dr. Francis Collins at the National Institutes of Health (NIH), where she provided strategic and operational leadership for a national Hepatitis C elimination initiative, which has since led to bipartisan legislation introduced in the United States Congress. She also advised the National Institute of Biomedical Imaging and Bioengineering (NIBIB), focusing on artificial intelligence and machine learning. Earlier, she served as a senior health policy advisor in the Biden-Harris White House and as a Senior Advisor to the NIH Director, playing a key leadership role in the federal COVID-19 response, including overseeing the “Say Yes! COVID Test” initiative and contributing to White House pandemic policy groups.

Prior to her federal service, Dr. Fleurence led the National Evaluation System for health Technology Coordinating Center (NESTcc) and PCORnet at the Patient-Centered Outcomes Research Institute (PCORI). Earlier in her career, she worked in health economics, outcomes research, and consulting.

Dr. Fleurence has received multiple NIH Director’s Awards, the HHS Secretary’s Award for Distinguished Service, and was named a National Champion for Global Hepatitis Elimination in 2023. She co-led the ISPOR Task Force on Electronic Health Records for Health Technology Assessment, co-chairs a new ISPOR Task Force on the use of Generative AI in Systematic Literature Reviews, serves on the ISPOR Working Group on Generative AI, and is an Associate Editor for Value in Health.

Jagpreet Chhatwal, PhD, is Director of the MGH Institute for Technology Assessment at Massachusetts General Hospital and Associate Professor at Harvard Medical School. His research centers on decision science, AI, and health economics. He leads research across multiple areas including hepatitis C, liver cancer, and opioid use disorders. Chhatwal has co-authored over 130 research articles, and his work has influenced health policies at the White House and World Health Organization. His research has been featured in major media outlets including The Wall Street Journal, New York Times, and Forbes. Additionally, he teaches meditation workshops and serves as a meditation coach, integrating mindfulness practices with his scientific work.